Market Closed -
Nasdaq
21:00:00 28/06/2024 BST
|
5-day change
|
1st Jan Change
|
1.23
USD
|
-5.38%
|
|
-1.60%
|
+29.19%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,736
|
1,759
|
444.2
|
464.3
|
610.6
|
-
|
-
|
Enterprise Value (EV)
1 |
1,664
|
1,479
|
340.5
|
341.4
|
410.5
|
486.2
|
465.2
|
P/E ratio
|
-5.27
x
|
-2.62
x
|
-1.31
x
|
-2.15
x
|
-6.04
x
|
-5.92
x
|
-6.47
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.58
x
|
1.19
x
|
0.13
x
|
0.23
x
|
0.46
x
|
0.44
x
|
0.42
x
|
EV / Revenue
|
2.47
x
|
1
x
|
0.1
x
|
0.17
x
|
0.31
x
|
0.35
x
|
0.32
x
|
EV / EBITDA
|
-22.4
x
|
-3.13
x
|
-1.14
x
|
-7.65
x
|
35.3
x
|
23.3
x
|
18.5
x
|
EV / FCF
|
-
|
-5,224,509
x
|
-1,633,729
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.25
x
|
1.28
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
103,500
|
472,802
|
477,944
|
487,644
|
496,437
|
-
|
-
|
Reference price
2 |
16.77
|
3.720
|
0.9295
|
0.9521
|
1.230
|
1.230
|
1.230
|
Announcement Date
|
01/03/21
|
23/02/22
|
28/02/23
|
12/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
672.9
|
1,472
|
3,477
|
2,034
|
1,342
|
1,384
|
1,468
|
EBITDA
1 |
-74.39
|
-472
|
-298.7
|
-44.66
|
11.62
|
20.84
|
25.15
|
EBIT
1 |
-92.71
|
-637
|
-370.9
|
-208.5
|
-121
|
-121.4
|
-134.1
|
Operating Margin
|
-13.78%
|
-43.27%
|
-10.67%
|
-10.25%
|
-9.01%
|
-8.77%
|
-9.13%
|
Earnings before Tax (EBT)
1 |
-91.58
|
-587.8
|
-338.8
|
-213.4
|
-121.3
|
-121.4
|
-134.1
|
Net income
1 |
-136.4
|
-587.8
|
-338.8
|
-213.4
|
-105.1
|
-108.2
|
-100.1
|
Net margin
|
-20.27%
|
-39.93%
|
-9.75%
|
-10.49%
|
-7.83%
|
-7.82%
|
-6.81%
|
EPS
2 |
-3.180
|
-1.420
|
-0.7115
|
-0.4425
|
-0.2037
|
-0.2077
|
-0.1901
|
Free Cash Flow
|
-
|
-283
|
-208.4
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-19.23%
|
-5.99%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/21
|
23/02/22
|
28/02/23
|
12/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
432
|
874.4
|
846.7
|
856.8
|
898.8
|
527.8
|
513.6
|
482.1
|
510.3
|
346.9
|
338.8
|
329.8
|
326.4
|
353.7
|
347.9
|
EBITDA
1 |
-154.8
|
-71.76
|
-87.47
|
-58.31
|
-81.12
|
-30.46
|
10.02
|
-5.13
|
-19.09
|
6.82
|
2.439
|
1.603
|
0.7586
|
14.79
|
-
|
EBIT
1 |
-186.8
|
-87.3
|
-102.5
|
-73.92
|
-107.2
|
-72.61
|
-28.81
|
-41.47
|
-65.66
|
-22.7
|
-33.2
|
-32.18
|
-32.88
|
-23
|
-
|
Operating Margin
|
-43.23%
|
-9.98%
|
-12.11%
|
-8.63%
|
-11.92%
|
-13.76%
|
-5.61%
|
-8.6%
|
-12.87%
|
-6.54%
|
-9.8%
|
-9.76%
|
-10.08%
|
-6.5%
|
-
|
Earnings before Tax (EBT)
1 |
-187.2
|
-75.31
|
-104.2
|
-75.31
|
-84.05
|
-72.61
|
-28.81
|
-41.47
|
-70.47
|
-23.17
|
-33.16
|
-32.16
|
-32.87
|
-23
|
-
|
Net income
1 |
-187.2
|
-75.31
|
-104.2
|
-75.31
|
-84.05
|
-72.61
|
-28.81
|
-41.47
|
-70.47
|
-19.17
|
-25.12
|
-25.79
|
-31
|
-27.53
|
-19.4
|
Net margin
|
-43.33%
|
-8.61%
|
-12.3%
|
-8.79%
|
-9.35%
|
-13.76%
|
-5.61%
|
-8.6%
|
-13.81%
|
-5.53%
|
-7.41%
|
-7.82%
|
-9.5%
|
-7.78%
|
-5.58%
|
EPS
2 |
-0.4400
|
-0.1600
|
-0.2188
|
-0.1577
|
-0.1759
|
-0.1516
|
-0.0601
|
-0.0863
|
-0.1463
|
-0.0390
|
-0.0485
|
-0.0511
|
-0.0604
|
-0.0546
|
-0.0400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/02/22
|
09/05/22
|
08/08/22
|
07/11/22
|
28/02/23
|
09/05/23
|
08/08/23
|
06/11/23
|
12/03/24
|
07/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
71.5
|
280
|
104
|
123
|
200
|
124
|
145
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-283
|
-208
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-476%
|
-76.7%
|
-67.3%
|
-30.4%
|
-24.2%
|
-21.8%
|
ROA (Net income/ Total Assets)
|
-45.1%
|
-96.5%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
302.1
|
609
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
1.150
|
0.7300
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-2.760
|
-0.6800
|
-0.4300
|
-
|
-
|
-
|
-
|
Capex
|
0.69
|
0.72
|
4.47
|
-
|
-
|
-
|
-
|
Capex / Sales
|
0.1%
|
0.05%
|
0.13%
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/21
|
23/02/22
|
28/02/23
|
12/03/24
|
-
|
-
|
-
|
Last Close Price
1.23
USD Average target price
1.333
USD Spread / Average Target +8.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +29.19% | 611M | | -3.27% | 469B | | +14.91% | 126B | | +10.39% | 93.91B | | -18.38% | 45.03B | | -10.66% | 35.38B | | -17.72% | 17.42B | | -23.05% | 2.72B | | -9.18% | 1.5B |
Other Managed Healthcare
|